| |
| |
|
| Insider
Information: |
Sachdev Amit |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
71,325 |
|
|
Indirect Shares
|
7,447 |
|
|
| Direct
Value |
$24,511,741 |
|
|
|
Indirect Value
|
$3,299,393 |
|
|
| Total
Shares |
78,772 |
|
|
| Total
Value |
$27,811,135 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP Chief Patient & Ex... |
2024-05-15 |
55,325 |
2024-05-15 |
7,447 |
Premium* |
|
|
Celladon Corp |
CLDN |
|
2022-03-11 |
16,000 |
2020-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
193 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2017-02-03 |
4 |
A |
$0.00 |
$58 |
D/D |
20,923 |
107,019 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2017-02-13 |
4 |
AS |
$87.68 |
$673,733 |
D/D |
(7,684) |
99,335 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2017-03-29 |
4 |
AS |
$106.30 |
$8,664,568 |
D/D |
(80,500) |
99,335 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2017-03-29 |
4 |
OE |
$37.86 |
$3,576,273 |
D/D |
80,500 |
179,835 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2017-05-15 |
4 |
AS |
$114.37 |
$13,267 |
D/D |
(116) |
99,335 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2017-06-01 |
4 |
AS |
$125.00 |
$3,812,500 |
D/D |
(30,500) |
99,335 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2017-06-01 |
4 |
OE |
$51.75 |
$1,578,375 |
D/D |
30,500 |
129,835 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2017-07-19 |
4 |
AS |
$161.00 |
$3,220,000 |
D/D |
(20,000) |
99,335 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2017-07-19 |
4 |
OE |
$77.31 |
$1,546,200 |
D/D |
20,000 |
119,335 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2017-07-21 |
4 |
AS |
$158.05 |
$1,386,691 |
D/D |
(8,625) |
90,710 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2017-10-31 |
4 |
AS |
$142.40 |
$5,802,084 |
D/D |
(40,000) |
50,710 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2017-11-15 |
4 |
AS |
$147.29 |
$12,225 |
D/D |
(83) |
50,710 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-01-19 |
4 |
OE |
$77.31 |
$2,589,732 |
D/D |
32,422 |
71,585 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-01-19 |
4 |
AS |
$157.67 |
$5,125,400 |
D/D |
(32,422) |
39,163 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-01-22 |
4 |
AS |
$160.00 |
$2,200,000 |
D/D |
(13,750) |
39,163 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-01-22 |
4 |
OE |
$83.36 |
$1,146,200 |
D/D |
13,750 |
52,913 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-01-23 |
4 |
AS |
$165.00 |
$960,960 |
D/D |
(5,824) |
39,163 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-01-23 |
4 |
OE |
$86.52 |
$503,892 |
D/D |
5,824 |
44,987 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-01-29 |
4 |
AS |
$170.00 |
$2,564,450 |
D/D |
(15,085) |
39,163 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-01-29 |
4 |
OE |
$91.05 |
$1,373,489 |
D/D |
15,085 |
54,248 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-02-05 |
4 |
AS |
$158.55 |
$736,800 |
D/D |
(4,520) |
39,163 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-02-05 |
4 |
OE |
$77.31 |
$367,327 |
D/D |
4,520 |
43,683 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
25,295 |
64,458 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-02-12 |
4 |
AS |
$149.22 |
$2,684,411 |
D/D |
(17,796) |
46,662 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
• – – |
2018-02-26 |
4 |
AS |
$170.00 |
$366,350 |
D/D |
(2,155) |
46,662 |
0 |
- |
|
193 Records found
|
|
Page 4 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
